Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2007 Jan 24;2007(1):CD005941.
doi: 10.1002/14651858.CD005941.pub2.

Probiotics for preventing preterm labour

M Othman  1 , J P Neilson, Z Alfirevic
Affiliations
Meta-Analysis

Probiotics for preventing preterm labour

M Othman et al. Cochrane Database Syst Rev. .

Abstract

Background: Preterm birth causes 60% to 80% of neonatal deaths. Survivors can experience life-long complications. The risk of preterm labour in the presence of maternal infection is thought to be 30% to 50%. Probiotics are defined as live micro-organisms which, when administered in an adequate amount, confer a health benefit on the host. They have been shown to displace and kill pathogens and modulate the immune response by interfering with the inflammatory cascade that leads to preterm labour and delivery. During pregnancy, local treatment restoring normal vaginal flora and acidity without systemic effects could be preferable to other treatment in preventing preterm labour.

Objectives: To evaluate the effectiveness and the safety of probiotics for preventing preterm labour and birth.

Search strategy: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (June 2006).

Selection criteria: All randomised controlled trials assessing the prevention of preterm birth in pregnant women and women planning pregnancy through the use of probiotics to treat or prevent urogenital infections.

Data collection and analysis: We extracted data using the prepared form and analysed with the Review Manager software.

Main results: We assessed four trials for inclusion in the review. One trial started in February 2005 and is still ongoing. We excluded one trial because there were no data to be extracted from the article. Of the two trials included in the review, one enrolled women after 34 weeks of pregnancy using oral fermented milk as probiotic, while the other study utilised commercially available yogurt to be used vaginally by women diagnosed with bacterial vaginosis in early pregnancy. Reduction in genital infection was the only prespecified clinical outcome for which the data were available; pooled results showed an 81% reduction in the risk of genital infection with the use of probiotics (risk ratio 0.19; 95% confidence interval 0.08 to 0.48).

Authors' conclusions: Although the use of probiotics appears to treat vaginal infections in pregnancy, there are currently insufficient data from trials to assess impact on preterm birth and its complications.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1.1
1.1. Analysis
Comparison 1 Any probiotics versus any type of control, Outcome 1 Neonatal death or severe morbidity.
1.2
1.2. Analysis
Comparison 1 Any probiotics versus any type of control, Outcome 2 Preterm birth less than 32 weeks.
1.3
1.3. Analysis
Comparison 1 Any probiotics versus any type of control, Outcome 3 Preterm birth less than 37 weeks.
1.8
1.8. Analysis
Comparison 1 Any probiotics versus any type of control, Outcome 8 Genital infection.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Luoto 2010 {published data only}
    1. Aaltonen J, Ojala T, Laitinen K, Piirainen TJ, Poussa TA, Isolauri E. Evidence of infant blood pressure programming by maternal nutrition during pregnancy: a prospective randomized controlled intervention study. Journal of Pediatrics 2008;152:79‐84. - PubMed
    1. Gronlund MM, Gueimonde M, Laitinen K, Kociubinski G, Gronroos T, Salminen S, et al. Maternal breast‐milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clinical and Experimental Allergy 2007;37(12):1764‐72. - PubMed
    1. Huurre A, Laitinen K, Rautava S, Korkeamaki M, Isolauri E. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double‐blind placebo‐controlled study. Clinical and Experimental Allergy 2008;38(8):1342–8. - PubMed
    1. Kaplas N, Isolauri E, Lampi AM, Ojala T, Laitinen K. Dietary counseling and probiotic supplementation during pregnancy modify placental phospholipid fatty acids. Lipids 2007;42(9):865–70. - PubMed
    1. Laitinen K, Poussa T, Isolauri E, The Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota Group. Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. British Journal of Nutrition 2009;101(11):1679–87. - PubMed
Neri 1993 {published data only}
    1. Neri A, Sabah G, Samra Z. Bacterial vaginosis in pregnancy treated with yoghurt. Acta Obstetricia et Gynecologica Scandinavica 1993;72(1):17‐9. - PubMed
Nishijima 2005 {published and unpublished data}
    1. Nishijima K, Shukunami K, Kotsuji F. Probiotics affects vaginal flora in pregnant women, suggesting the possibility of preventing preterm labor. Journal of Clinical Gastroenterology 2005;39(5):447‐8. - PubMed

References to studies excluded from this review

Shadid 2007 {published data only}
    1. Shadid R, Haarman M, Knol J, Theis W, Beermann C, Rjosk‐Dendorfer D, et al. Effects of galactooligosaccharide and long‐chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity ‐ a randomized, double‐blind, placebo‐controlled study. American Journal of Clinical Nutrition 2007;86:1426‐37. - PubMed
Thiagarajan 1998 {published data only}
    1. Thiagarajan M. Evaluation of the use of yogurt in treating bacterial vaginosis in pregnancy. Journal of Clinical Epidemiology 1998;51 Suppl 1:S22.

References to studies awaiting assessment

Bocking 2005 {published data only}
    1. Bocking A. Effect of probiotic lactobacilli on vaginal flora of pregnant women at high risk for preterm delivery. www.clinicaltrials.gov (accessed 2 November 2005).
Krauss‐Silva 2006 {published data only}
    1. Krauss‐Silva L. Probiotics for the prevention of premature birth and neonatal related morbidity (ongoing trial). ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 21 March 2006).

Additional references

Andreu 2004
    1. Andreu A. Lactobacillus as a probiotic for preventing urogenital infections. Reviews in Medical Microbiology 2004;15:1‐6.
Bejar 1981
    1. Bejar R, Curbelo V, Davis C, Gluck L. Premature labor. II. Bacterial sources of phospholipase. Obstetrics & Gynecology 1981;57(4):479‐82. - PubMed
Bengmark 2001
    1. Bengmark S. Pre‐, pro‐ and synbiotics. Current Opinion in Clinical Nutrition and Metabolic Care 2001;4(6):571‐9. - PubMed
Chaim 1997
    1. Chaim W, Mazor M, Leiberman JR. The relationship between bacterial vaginosis and preterm birth. A review. Archives of Gynecology and Obstetrics 1997;259(2):51‐8. - PubMed
Collins 1999
    1. Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. American Journal of Clinical Nutrition 1999;69(5):1052S‐1057S. - PubMed
Cram 2002
    1. Cram LF, Zapata MI, Toy EC, Baker B. Genitourinary infections and their association with preterm labour. American Family Physician 2002;65(2):241‐8. - PubMed
Crowther 2005
    1. Crowther CA, Thomas N, Middleton P, Chua M, Esposito M. Treating periodontal disease for preventing preterm birth in pregnant women. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD005297] - DOI - PMC - PubMed
Deeks 2001
    1. Deeks JJ, Altman DG, Bradbury MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta‐analysis. London: BMJ Books, 2001.
Egger 1997
    1. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315(7109):629‐34. - PMC - PubMed
Elmer 2001
    1. Elmer GW. Probiotics: “Living drugs”. American Journal of Health‐System Pharmacology 2001;58(12):1101‐9. - PubMed
Gates 2005
    1. Gates S. Methodological Guidelines. In: The Editorial Team. Pregnancy and Childbirth Group. About The Cochrane Collaboration (Collaborative Review Groups (CRGs)) 2005, Issue 2.
Harbord 2006
    1. Harbord RM, Egger M, Sterne JA. A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints. Statistics in Medicine 2006;25(20):3443‐57. - PubMed
Higgins 2005
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.4 [updated March 2005]. In: The Cochrane Library, Issue 2, 2005. Chichester, UK: John Wiley & Sons, Ltd.
Higgins 2009
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane‐handbook.org.
Howe 1999
    1. Howe L, Wiggins R, Soothill PW, Millar MR, Horner PJ, Coroeld AP. Mucinase and sialidase activity of the vaginal microflora: implications for the pathogenesis of preterm labour. International Journal of STD & AIDS 1999;10(7):442‐7. - PubMed
Kiss 2004
    1. Kiss H, Petricevic L, Husslein P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. BMJ 2004;329(7462):371. - PMC - PubMed
Klein 2004
    1. Klein LL, Gibbs RS. Use of microbial cultures and antibiotics in the prevention of infection‐associated preterm birth. American Journal of Obstetrics and Gynecology 2004;190(6):1493‐502. - PubMed
Leitich 2003
    1. Leitich H, Brunbauer M, Bodner‐Adler B, Kaider A, Egarter C, Husslein P. Antibiotic treatment of bacterial vaginosis in pregnancy: a meta‐analysis. American Journal of Obstetrics and Gynecology 2003;188(3):752‐8. - PubMed
McGregor 1997
    1. McGregor JA, French JI. Pathogenesis to treatment: preventing preterm birth mediated by infection. Infectious Diseases in Obstetrics and Gynecology 1997;5:106‐14. - PMC - PubMed
Petrou 2001
    1. Petrou S, Sach T, Davidson L. The long term costs of preterm birth and low birth weight: results of a systematic review. Child: Care, Health and Development 2001;27(2):97‐115. - PubMed
Reid 2001
    1. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunology and Medical Microbiology 2001;30(1):49‐52. - PubMed
Reid 2002a
    1. Reid G. Probiotics for urogenital health. Nutrition in Clinical Care 2002;5(1):3‐8. - PubMed
Reid 2002b
    1. Reid G, Burton J. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes and Infection 2002;4(3):319‐24. - PubMed
Reid 2003a
    1. Reid G, Bocking A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. American Journal of Obstetrics and Gynecology 2003;189(4):1202‐8. - PubMed
Reid 2003b
    1. Reid G, Jass J, Sebulsky MT, McCormick JK. Potential uses of probiotics in clinical practice. Clinical Microbiology Reviews 2003;16(4):658‐72. - PMC - PubMed
Reid 2003c
    1. Reid G, Bruce AW. Urogenital infections in women: can probiotics help?. Postgraduate Medical Journal 2003;79(934):428‐32. - PMC - PubMed
Reid 2003d
    1. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, et al. Oral use of Lactobacillus rhamnosus GR‐1 and L. fermentum RC‐14 significantly alters vaginal flora: randomized, placebo‐controlled trial in 64 healthy women. FEMS Immunology and Medical Microbiology 2003;35(2):131‐4. - PubMed
Reid 2004
    1. Reid G, Burton J, Devillard E. The rationale for probiotics in female urogenital healthcare. Medscape General Medicine 2004;6(1):49. - PMC - PubMed
RevMan 2003 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
RevMan 2008 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
Riggs 2004
    1. Riggs MA, Klebanoff MA. Treatment of vaginal infections to prevent preterm birth: a meta‐analysis. Clinical Obstetrics and Gynecology 2004;47(4):796‐807. - PubMed
Romero 2002
    1. Romero R, Espinoza J, Chaiworapongsa T, Kalache K. Infection and prematurity and the role of preventive strategies. Seminars in Neonatology 2002;7(4):259‐74. - PubMed
Shennan 2006
    1. Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G, et al. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET study. BJOG: an international journal of obstetrics and gynaecology 2006;113(1):65‐74. - PubMed
Sieber 1998
    1. Sieber R, Dietz UT. Lactobacillus acidophilus and yogurt in the prevention and therapy of bacterial vaginosis. International Dairy Journal 1998;8:599‐607.
Ugwumadu 1999
    1. Ugwumadu AH, Hay P. Bacterial vaginosis: sequelae and management. Current Opinion in Infectious Diseases 1999;12(1):53‐9. - PubMed
VIPSG 1995
    1. Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibb RS, Martin DH, et al. Association between bacterial vaginosis and preterm delivery of a low‐birth‐weight infant. The Vaginal Infections and Prematurity Study Group. New England Journal of Medicine 1995;333(26):1737‐42. - PubMed
Wilks 2004
    1. Wilks M, Wiggins R, Whiley A, Hennessy E, Warwick S, Porter H, et al. Identification and H2O2 production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome. Journal of Clinical Microbiology 2004;42(2):713‐7. - PMC - PubMed
Yost 2000
    1. Yost NP, Cox SM. Infection and preterm labour. Clinical Obstetrics and Gynecology 2000;43(4):759‐67. - PubMed

MeSH terms